Richmond Pharmacology is pleased to join the Women’s Health Horizons London Summit hosted by the Royal College of Obstetricians and Gynaecologists in London, 22 September 2026.
As one of Europe’s leading events dedicated to pharmacovigilance, drug safety, risk management, and patient‑centric safety innovation, the World Drug Safety Congress brings together global industry leaders, regulators, technology partners, and research organisations to shape the future of safety science in healthcare.
Representing Richmond Pharmacology:
Dr Lisa Campbell will be Part of the Panel titled "From Lab to Market: Regulation, Risk and the Realities of Commercialisation"
The discussion will explore what it really takes to move a women’s health innovation from a promising idea into real-world use and cover key considerations including:
• Navigating regulatory pathways and expectations
• Building robust and clinically meaningful evidence
• Understanding risk and liability
• Creating a viable route to scale and real-world deployment
We look forward to Lisa sharing her regulatory perspective and contributing to this important conversation on advancing innovation in women’s health.
Connect With Us
If you are attending the Women's Health Horizons, London Summit 2026 and would like to explore collaboration or development opportunities email us at:
📧 fasteranswers@richmondpharmacology.com
.svg){kind=small}
.avif)
